Cision PR Newswire

Asieris Pharmaceuticals Releases 2026 Semi-Annual Report: Core Product Commercialization Delivers, Entering a Harvest Period as the Company Accelerates Its Transition to Biopharma

SHANGHAI, Aug. 28, 2026 /PRNewswire/ -- Asieris Pharmaceuticals today released its 2026 Semi-Annual Report, showing comprehensive progress across all business segments. With the gradual realization of commercial launch and international expansion for its core products, the company is accelerating its transition from Biotech to Biopharma: CEVIRA®, the world's first...

McDonald’s China Triumph: Harnessing Tencent Cloud’s Partnership in Digital Transformation and Consumer Engagement

Enhancing McDonald's China digital ordering system to efficiently manage both regular peak times and promotional surges HONG KONG, Feb. 14, 2025 /PRNewswire/ --...

Fosun International Continues to be Recognized in the S&P Global’s Sustainability Yearbook 2025

HONG KONG, Feb. 14, 2025 /PRNewswire/ -- On 12 February 2025, S&P Global released the Sustainability Yearbook 2025. Fosun International Limited (HKEX Stock Code: 00656,...

Axel Klarmeyer Joins Chamlion as CEO, Chamlion International

NANJING, China, Feb. 14, 2025 /PRNewswire/ -- Chamlion, a pioneer in integrated dental 3D printing solutions, is pleased to announce the appointment of Axel...

ASEAN Foundation and Google.org Lead Regional Policy Forum to Drive AI Literacy Forward

JARKATA, Indonesia, Feb. 14, 2025 /PRNewswire/ -- The ASEAN Foundation, supported by Google.org, successfully hosted the 1st Regional Policy Convening of AI Ready ASEAN at...

Akeso Announces IND Acceptance for AK139, a Bispecific Antibody Targeting IL-4Rα and ST2 for Respiratory and Skin Diseases

HONG KONG, Feb. 14, 2025 /PRNewswire/ -- Akeso, Inc. (9926. HK) ("Akeso" or the "Company") is pleased to announce the acceptance of its Investigational...